We are live on ! Find out more
WMGI

Wright Medical Group Inc
WMGI

Delisted

WMGI was delisted on the 10th of November, 2020.

155 hedge funds and large institutions have $2.31B invested in Wright Medical Group Inc in 2018 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 50 increasing their positions, 50 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 50

7% less funds holding

Funds holding: 167155 (-12)

11% less capital invested

Capital invested by funds: $2.6B → $2.31B (-$285M)

12% less call options, than puts

Call options by funds: $2.27M | Put options by funds: $2.59M

39% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 31

Holders
155
Holders Change
-12
Holders Change %
-7.19%
% of All Funds
3.55%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
19
Increased
50
Reduced
50
Closed
31
Calls
$2.27M
Puts
$2.59M
Net Calls
-$321K
Net Calls Change
+$6.7M
Name Holding Trade Value Shares
Change
Change in
Stake
GT
26
Glenmede Trust
Pennsylvania
$19.1M
Geode Capital Management
27
Geode Capital Management
Massachusetts
$18.8M +$119K +5,559 +0.6%
PCM
28
Peregrine Capital Management
Minnesota
$18.7M -$991K -46,204 -5%
Capital World Investors
29
Capital World Investors
California
$17.5M
ECP
30
Elk Creek Partners
Colorado
$16.9M -$339K -15,816 -2%
CCM
31
Camber Capital Management
Massachusetts
$16.2M +$5.15M +240,000 +42%
Renaissance Technologies
32
Renaissance Technologies
New York
$16M +$16.4M +766,400 +1,955%
FAM
33
Foundation Asset Management
New York
$15.7M -$798K -37,215 -5%
UBS AM
34
UBS AM
Illinois
$14.3M -$44.4M -2,068,865 -74%
KTA
35
Keeley-Teton Advisors
Illinois
$13M -$583K -27,202 -4%
O
36
OppenheimerFunds
New York
$12.8M +$63K +2,936 +0.5%
DM
37
Deerfield Management
New York
$12.6M +$13.6M +634,000 New
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$11.8M -$106K -4,928 -0.8%
GF
39
Gabelli Funds
New York
$11.1M
BG
40
Bellevue Group
Switzerland
$10.7M
Charles Schwab
41
Charles Schwab
California
$10.5M +$662K +30,869 +6%
ClearBridge Investments
42
ClearBridge Investments
New York
$10.2M
PCM
43
Penn Capital Management
Pennsylvania
$9.91M -$195K -9,087 -2%
Bank of New York Mellon
44
Bank of New York Mellon
New York
$9.46M +$181K +8,462 +2%
CC
45
Chicago Capital
Illinois
$8.67M +$9.37M +437,067 New
Morgan Stanley
46
Morgan Stanley
New York
$8.42M -$11.6M -541,578 -56%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$8.25M
D.E. Shaw & Co
48
D.E. Shaw & Co
New York
$7.47M -$3.39M -157,986 -30%
FMI
49
Factory Mutual Insurance
Massachusetts
$7.43M
State of Tennessee, Department of Treasury
50
State of Tennessee, Department of Treasury
Tennessee
$7.08M -$12.3M -574,829 -62%

WMGI Hedge Fund Activity: Q1 2018 in Review

155 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Wright Medical Group Inc (WMGI) for Q1 2018, worth a combined $2.31B — down 11% from $2.6B a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of WMGI and 19 opened new positions — a net loss of 12 holders — while 50 trimmed existing stakes and 50 added.

The largest buyer was Capital Research Global Investors, adding an estimated $30.7M. The largest seller was UBS AM, cutting an estimated $44.4M.

  • 155 institutional investors held Wright Medical Group Inc (WMGI) as of Q1 2018, down from 167 in Q4 2017.
  • Funds reported $2.31B of Wright Medical Group Inc stock for Q1 2018, down 11% quarter-over-quarter.
  • 19 funds opened new Wright Medical Group Inc positions in Q1 2018 and 31 closed out, a net change of -12 holders.
  • The largest Wright Medical Group Inc buyer in Q1 2018 was Capital Research Global Investors, an estimated $30.7M added.
  • The largest Wright Medical Group Inc seller in Q1 2018 was UBS AM, an estimated $44.4M sold.

Based on aggregated 13F filings for Q1 2018.